Dolan E, Gualano B, Rawson ES
These medications work by mimicking the hormone GLP-1, helping regulate appetite and blood sugar
Based on investigational protocol reports and the clinical trial data, most subjects begin to see measurable changes in body composition at 4 to 6 weeks on a consistent daily protocol at 300 mcg
FGF21 selectively uses Klotho as its co-receptor, whereas, FGF23 uses Klotho
Signs you are escalating too fast Watch for these indicators that your dose is advancing too quickly for your postpartum body: Persistent nausea lasting more than three days after a dose increase Inability to consume at least 1,500 calories daily (1,800 or more if breastfeeding) Noticeable drop in breast milk supply Fatigue significantly worse than your postpartum baseline Weight loss exceeding three pounds per week consistently Dizziness or lightheadedness, especially when standing If any of these occur, the standard recommendation is to hold at your current dose for an additional four weeks before attempting another increase